[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07634640":3,"trial-entities:NCT07634640":78,"trial-summary:NCT07634640":82},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":20,"study_type":22,"primary_purpose":14,"phases":23,"enrollment_info":25,"interventions":28,"primary_outcomes":35,"secondary_outcomes":39,"sex":40,"minimum_age":41,"maximum_age":42,"healthy_volunteers":15,"eligibility_criteria":43,"std_ages":49,"locations":52,"central_contacts":67,"overall_officials":73,"references":76,"see_also_links":77},"NCT07634640","202300847","Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction","Omega-3 Fatty Acids and Myocardial Inflammation in HFpEF: Preliminary Data and Next Steps","RECRUITING","2027-05-31","2026-05","2026-06-09","2023-11-03","University of Florida","OTHER",false,"Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours",null,[19],"Heart Failure With Preserved Ejection Fraction (HFPEF)",[21],"heart failure with preserved ejection fraction","INTERVENTIONAL",[24],"EARLY_PHASE1",{"count":26,"type":27},70,"ESTIMATED",[29],{"type":30,"name":31,"description":32,"armGroupLabels":33},"DRUG","Ferumoxytol infusion","Ferumoxytol infusion followed by cardiac MRI",[34],"Single arm study of subjects with HFpEF",[36],{"measure":37,"timeFrame":38},"detection of inflammation","72 hours",[],"ALL","18 Years","85 Years",{"inclusion":44,"exclusion":46,"raw_text":48},[45],"HFpEF",[47],"Renal insufficiency","Inclusion Criteria:\n\n* HFpEF\n\nExclusion Criteria:\n\n* Renal insufficiency",[50,51],"ADULT","OLDER_ADULT",[53],{"facility":13,"status":8,"city":54,"state":55,"zip":56,"country":57,"contacts":58,"geoPoint":64},"Gainesville","Florida","32608","United States",[59],{"name":60,"role":61,"phone":62,"email":63},"Ellen C Keeley, MD, MS","CONTACT","800-265-0820","ellen.keeley@medicine.ufl.edu",{"lat":65,"lon":66},29.65163,-82.32483,[68,69],{"name":60,"role":61,"phone":62,"email":63},{"name":70,"role":61,"phone":71,"email":72},"Vanessa H Scheuble","800-555-0820","Vanessa.scheuble@medicine.ufl.edu",[74],{"name":60,"affiliation":13,"role":75},"PRINCIPAL_INVESTIGATOR",[],[],{"nct_id":4,"conditions":79,"biomarkers":81},[80],"Heart failure with normal ejection fraction",[],{"nct_id":4,"found":15,"summary":17,"prompt_version":17}]